An ordinary North Dakota investment-adviser representative files Form U4 through IARD and pays $60 initially and at annual renewal. The ordinary qualification route is Series 65 or SIE plus Series 7 plus Series 66, subject to the current two-year lapse rule and bounded grandfathering or listed current good-standing designation treatment. Registration must be effective before activity begins.

Prelicensing education

Education requirement explanation
Qualification and any accepted alternative or waiver must match the current state rule; examination passage alone is not registration.

Background

Fingerprint / background instructions
Form U4 disclosures and regulator follow-up apply; no separate fingerprint requirement is inferred unless expressly documented.

Application

Application fee
The current official regulator page lists a $60 initial state fee and $60 annual renewal fee; no separate system charge is asserted.
Application channel / system
The firm files Form U4 through IARD; filing and examination passage do not create registration.
Official application reference
https://www.insurance.nd.gov/securities/investment-advisers-and-ia-representatives-registration

Renewal & maintenance

CE hours
No general North Dakota state IAR CE mandate is asserted from the reviewed current regulator page and policy statement.

Portability

Portability / mobility notes
Registration is firm-, function-, and jurisdiction-specific; examination validity and approval are separate.

Military / veteran / spouse

Military experience / education credit
No broad military credit is asserted unless expressly documented.

Source governance

Primary authoritative source
https://www.insurance.nd.gov/securities/investment-advisers-and-ia-representatives-registration
Last verified date
2026-08-31
Verification status
Verified
Review / recheck date
2026-09-30

Compare education providers

Alphabetical options; compensation never determines eligibility or placement. Confirm the exact course and jurisdiction before enrolling. This directory is not exhaustive.

No currently verified published offerings match. Check official provider and regulator resources; additional options may exist.